Common type 2 diabetes medication may raise risk of bladder cancer
Links shared publicly online about this topic.
- 272total visits
Common type 2 diabetes medication may raise risk of bladder cancer
The type 2 diabetes medication pioglitazone may be associated with an increased risk of bladder cancer, according to a new review of Food and Drug Administration data conducted by a team of Italian researchers.
View full resource at endocrineweb.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Bladder Cancer, Urinary System, Drug
Most Recently Shared on May 23, 2011 at 5:39 pm By:
Common type 2 diabetes medication may raise risk of bladder cancer http://dlvr.it/SjxJ2
Advertisement
